The synthesis of hexahydro‐11H,15H‐dibenzo[f,h] [1,3]oxazino[3,2‐b]isoquinolin‐15‐ones was achieved via photoinduced rearrangement of 3‐biphenyl‐1‐hydroxypropyl‐pyridin‐2(1 H )‐ones with a 313 nm UV light. Trans ‐(8b,15a)‐9a‐β‐hexahydro‐11H,15H‐dibenzo[f,h][1,3]oxazino[3,2‐b]isoquinolin‐15‐ones and trans ‐(8b,15a)‐9a‐α‐hexahydro‐11H,15H‐dibenzo[f,h][1,3] oxazino[3,2‐b]isoquinolin‐15‐ones were obtained in 76–92% yields via a one‐pot reaction. Alternatively, irradiation of 3‐biphenyl‐1‐hydroxypropyl‐pyridin‐2(1 H )‐ones in the presence of HCl aqueous solution (1 M) led to the formation of cis ‐(8b,15a)‐9a‐β‐hexahydro‐11H,15H‐dibenzo[f,h][1,3]oxazino[3,2‐b]isoquinolin‐15‐ones and cis ‐(8b,15a)‐9a‐α‐hexahydro‐11H,15H‐dibenzo[f,h][1,3]oxazino[3,2‐b]isoquinolin‐15‐ones by a one‐pot reaction of photo 6π ‐electrocyclization and addition cyclization. The construction of a partially dearomatized phenanthrene ring and quinolizidinone ring was achieved by a one‐pot reaction, with controlled cis / trans stereochemistry.
No takes yet. Share an insight, caveat, or question.
Sui et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: